RGLSRegulus Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsMay 8
Mkt Cap$564.95M
Vol9.34M
55

Bullish Sentiment

How do you feel about RGLS?

News
all
press releases
News Placeholder
Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead
Regulus Therapeutics shares surged after Novartis announced a $1.7 billion acquisition, but analysts downgraded the stock citing limited upside. Retail sentiment remained bullish, with speculation of a higher bid or FDA-driven gains.
Stocktwits
News Placeholder
Regulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From Novartis
According to the terms of the deal, Novartis, through a subsidiary, will initiate a tender offer to acquire all of Regulus' outstanding shares for an initial price of $7.00 per share or $800 million.
Stocktwits
<
...
1
>

Advertisement|Remove ads.